P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance
Authors:
- Yuke HeYHYuke He
- Antonia E. GallmanAGAntonia E. Gallman
- Chengmei XieCXChengmei Xie
- Qian ShenQSQian Shen
- Jianyang MaJMJianyang Ma
- Finn D. WolfreysFWFinn D. Wolfreys
- Moriah SandyMSMoriah Sandy
- Todor ArsovTATodor Arsov
- Xiaoqian WuXWXiaoqian Wu
- Yuting QinYQYuting Qin
- Pingjing ZhangPZPingjing Zhang
- Simon JiangSJSimon Jiang
Open Access
- 10 December 2021
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (1)
Abstract
B cell self-tolerance is maintained through multiple checkpoints, including restraints on intracellular signaling and cell trafficking. P2RY8 is a receptor with established roles in germinal center (GC) B cell migration inhibition and growth regulation. Somatic P2RY8 variants are common in GC-derived B cell lymphomas. Here, we identify germline novel or rare P2RY8 missense variants in lupus kindreds or the related antiphospholipid syndrome, including a “de novo” variant in a child with severe nephritis. All variants decreased protein expression, F-actin abundance, and GPCR-RhoA signaling, and those with stronger effects increased AKT and ERK activity and cell migration. Remarkably, P2RY8 was reduced in B cell subsets from some SLE patients lacking P2RY8 gene variants. Low P2RY8 correlated with lupus nephritis and increased age-associated B cells and plasma cells. By contrast, P2RY8 overexpression in cells and mice restrained plasma cell development and reinforced negative selection of DNA-reactive developing B cells. These findings uncover a role of P2RY8 in immunological tolerance and lupus pathogenesis.Keywords
Funding Information
- Renji Hospital (808.001.03)
- National Natural Science Foundation of China (81873879)
- National Health and Medical Research Council
- Centres of Research Excellence
- National Natural Science Foundation of China (81801594)
- National Institute of Allergy and Infectious Disease (F30AI150061)
- Cancer Research Institute
- Howard Hughes Medical Institute
- University of California, San Francisco
- National Institutes of Health (R01 AI045073)
- California Lupus Epidemiology Study
- Centers for Disease Control and Prevention (U01DP006486, P30AR070115)
- National Natural Science Foundation of China (31630021, 31930037)
- Shanghai Municipal Key Medical Center Construction Project (2017ZZ01024-002)
- Shenzhen Science and Technology Project (JCYJ20180504170414637)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201602087)
This publication has 58 references indexed in Scilit:
- BioGPS and MyGene.info: organizing online, gene-centric informationNucleic Acids Research, 2012
- Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaLeukemia, 2012
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingProceedings of the National Academy of Sciences, 2012
- Luciferase Reporter Assay System for Deciphering GPCR PathwaysCurrent Chemical Genomics, 2010
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemiaNature Genetics, 2009
- Wiskott–Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activationImmunobiology, 2009
- CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of LupusThe Journal of Immunology, 2009
- Regulation of Class-Switch Recombination and Plasma Cell Differentiation by Phosphatidylinositol 3-Kinase SignalingImmunity, 2006
- Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5Nature Immunology, 2004
- A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell MovementsJournal of Experimental Medicine, 2001